Results 121 to 130 of about 4,229 (207)

Beyond hemostasis: a narrative review on the multifaceted therapeutic potential of Ankaferd Blood Stopper. [PDF]

Ann Med Surg (Lond)
Tibi SE, Nazir MH, Nazir S, Patel BD, Misra G, Patel T, Nasir F, Farhan M, Sardarova N, Anand N.   +9 more
europepmc   +1 more source

CAMP: a modular metagenomics analysis system for integrated multistep data exploration. [PDF]

NAR Genom Bioinform
Mak L, Tierney B, Wei W, Ronkowski C, Toscan RB, Turhan B, Toomey M, Andrade-Martínez JS, Fu C, Lucaci AG, Solano AHB, Setubal JC, Henriksen JR, Zimmerman S, Kopbayeva M, Noyvert A, Iwan Z, Kar S, Nakazawa N, Meleshko D, Horyslavets D, Kantsypa V, Frolova A, Kahles A, Danko D, Elhaik E, Labaj P, Mangul S, International MetaSUB Consortium , Mason CE, Hajirasouliha I.   +30 more
europepmc   +1 more source

Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label, multicentre, randomised, non-inferiority D3/PENTA 21 trial. [PDF]

EBioMedicine
Bevers LAH, Toledo G, Kisekka M, Kaudha E, Ahimbisibwe GM, Deprez I, Arumugan T, Variava E, Violari A, White I, Bbuye D, Nanduudu A, Mulwanyi E, Amuge P, Rutebarika DA, Kekitiinwa A, Kityo C, Musoke P, Archary M, Boles J, Thomason MJ, de Wildt SN, Giaquinto C, Colbers A, Burger DM, Buchanan AM, Chan MK, Jacobs TG, Turkova A, D3 TRIAL TEAM.   +29 more
europepmc   +1 more source

Thomas Morgan and a Heat-Based Variety of Newtonian Medicine. [PDF]

Uisahak
Joo E.
europepmc   +1 more source

[Origin of Syphilis in Europe: End of a Controversy?] [PDF]

Med Trop Sante Int
Louis JP, Louis F.
europepmc   +1 more source

Biblical Stories on the Medieval and Early Modern Stage: A Transnational Approach. [PDF]

J Bible Its Recept
Bloemendal J.
europepmc   +1 more source

Abstract Supplement HIV Glasgow 8–11 November 2026, Glasgow, UK/Virtual

Journal of the International AIDS Society, Volume 29, Issue S6, November 2026.
wiley   +1 more source

BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan Africa. [PDF]

Contemp Clin Trials
Katongole F, Arumugam T, Jennings A, Mutata C, Ssebunya P, Wamboi C, Green A, Bwakura-Dangarembizi M, Kityo C, Siika A, Archary M, Jafta L, Namukwaya S, Seeley J, Mugerwa H, Walker S, Apoto N, Thomason MJ, Ford D, Pett SL, Kekitiinwa AR, BREATHER Plus trial team.   +21 more
europepmc   +1 more source